Columbia Capital’s iShares Biotechnology ETF IBB Stock Holding History

Columbia Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$588K	Sell	5,814 -7,629	-57%	-$741K	0.64%	76
2014 Q3	$1.23M	Buy	13,443 +1,770	+15%	+$155K	1.64%	29
2014 Q2	$1M	Hold	11,673	–	–	0.79%	53
2014 Q1	$893K	Buy	11,673 +1,455	+14%	+$121K	0.64%	64
2013 Q4	$773K	Buy	10,218 +6,912	+209%	+$490K	0.68%	52
2013 Q3	$232K	Buy	+3,306	New	+$217K	0.21%	55

Other funds holding IBB

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Columbia Capital's IBB Position: Q4 2014 in Review

Columbia Capital reduced its iShares Biotechnology ETF (IBB) stake by 57% in Q4 2014, selling an estimated $741K and leaving 5,814 shares worth $588K. The position accounts for 0.64% of the portfolio, ranked #76.

Columbia Capital first reported a position in IBB in Q3 2013 and has held it in 6 quarters since. The position peaked at $1.23M in Q3 2014. 369 funds tracked by Wall St. Rank hold IBB as of Q4 2014.

Columbia Capital held 5,814 shares of iShares Biotechnology ETF worth $588K as of Q4 2014.
Columbia Capital sold 7,629 iShares Biotechnology ETF shares in Q4 2014, an estimated $741K.
iShares Biotechnology ETF made up 0.64% of Columbia Capital's portfolio in Q4 2014, its #76 holding.
Columbia Capital first reported a position in iShares Biotechnology ETF in Q3 2013 and has held it in 6 quarters since.
Columbia Capital's iShares Biotechnology ETF position peaked at $1.23M in Q3 2014.
369 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2014.

Based on Columbia Capital's 13F filing for Q4 2014, filed 11 Feb 2015.